Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for CardioGenics Holdings Inc. (CGNH : OTC)

• Company Description    CardioGenics Inc., through its operating subsidiaries, develops ultra-sensitive analyzers and other products targeting the immunoassay segment of the Point-Of-Care IVD testing market. It has developed the QL Care Analyzer, a Point-Of-Care immuno-analyzer, which will run a number of diagnostic tests under development, the first of which will be a series of cardiovascular diagnostic tests. The Company has also developed a method for silver coating paramagnetic microspheres (a fundamental platform component of immunoassay equipment), which improve instrument sensitivity to light. CardioGenics's principal offices are located in Mississauga, Ontario, Canada. Number of Employees:

• Price / Volume Information    Yesterday's Closing Price: $0.00 Daily Weekly Monthly 20 Day Moving Average: 1,317 shares Shares Outstanding: (millions) Market Capitalization: $ (millions) Beta: 1.08 52 Week High: $0.01 52 Week Low: $0.00 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week % % 12 Week % % Year To Date % %

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 6295 Northam Drive Unit 8 - Mississauga,A6 L4V 1W8 CAN ph: 905-673-8501 fax: 905-673-9865 invest@jagnotes.com http://www.cardiogenics.com

• General Corporate Information    Officers J Neil Tabatznik - Director/Acting Chairman Yahia Gawad - Director & Chief Executive Officer James A. Essex - Chief Financial Officer Linda J. Sterling - Director & Secretary Karim Murabet - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 14160X203 SIC: 7389 Fiscal Year Fiscal Year End: October Last Reported Quarter: - Next Expected EPS Date: - Share - Related Items Shares Outstanding: Most Recent Split Date: (:1) Beta: 1.08 Market Capitalization: $ (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: -

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 04/30/23 - - 01/31/23 - - 10/31/22 - - ROA 04/30/23 - - 01/31/23 - - 10/31/22 - - Current Ratio 04/30/23 - - 01/31/23 - - 10/31/22 - - Quick Ratio 04/30/23 - - 01/31/23 - - 10/31/22 - - Operating Margin 04/30/23 - - 01/31/23 - - 10/31/22 - - Net Margin 04/30/23 - - 01/31/23 - - 10/31/22 - - Pre-Tax Margin 04/30/23 - - 01/31/23 - - 10/31/22 - - Book Value 04/30/23 - - 01/31/23 - - 10/31/22 - - Inventory Turnover 04/30/23 - - 01/31/23 - - 10/31/22 - - Debt-to-Equity 04/30/23 - - 01/31/23 - - 10/31/22 - - Debt-to-Capital 04/30/23 - - 01/31/23 - - 10/31/22 - -

Powered by Zacks Investment Research ©